SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-19-000048
Filing Date
2019-05-14
Accepted
2019-05-14 16:11:47
Documents
57
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dare-03312019x10q.htm 10-Q 636907
2 EXHIBIT 31.1 exhibit311.htm EX-31.1 18340
3 EXHIBIT 31.2 exhibit312.htm EX-31.2 17669
4 EXHIBIT 32.1 exhibit321.htm EX-32.1 4956
5 EXHIBIT 32.2 exhibit322.htm EX-32.2 5043
12 darecovera03.jpg GRAPHIC 147455
  Complete submission text file 0001401914-19-000048.txt   3992463

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dare-20190331.xml EX-101.INS 507648
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20190331.xsd EX-101.SCH 51736
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20190331_cal.xml EX-101.CAL 47222
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20190331_def.xml EX-101.DEF 200033
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20190331_lab.xml EX-101.LAB 551153
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20190331_pre.xml EX-101.PRE 305683
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 19822822
SIC: 2834 Pharmaceutical Preparations